Health & Research Goals
HGH (Human Growth Hormone / Somatropin)
HGH (Hormona de Crecimiento Humana / Somatropina)
Human Growth Hormone (HGH), also called somatropin, is a 191-amino acid peptide hormone produced by the anterior pituitary gland. …
Primary Description
Human Growth Hormone (HGH), also called somatropin, is a 191-amino acid peptide hormone produced by the anterior pituitary gland. It is the master anabolic and metabolic hormone responsible for growth, body composition, cellular repair, and metabolism. HGH stimulates the liver to produce Insulin-like Growth Factor 1 (IGF-1), which mediates most of HGH's anabolic effects on muscle, bone, and tissue. Endogenous HGH is released in pulsatile fashion during sleep, fasting, and exercise. HGH levels peak during puberty and decline progressively from the late 20s — a process associated with body composition changes, reduced recovery, and metabolic deterioration. Exogenous HGH (somatropin) is FDA-approved for specific medical indications including growth hormone deficiency and is widely used off-label in anti-aging and performance contexts. NOTE: This peptide page was not found on PepedHub; content is based on established clinical knowledge.
Key Benefits
- Direct GH replacement — strongest GH effect available (not a secretagogue)
- Lean mass gain, visceral fat reduction, improved body composition
- Enhanced recovery, tissue repair, and collagen synthesis
- Improved sleep quality and bone density
Lyophilized somatropin is stable at 2–8°C for up to 3 years. Reconstituted: refrigerate at 2–8°C, use within 14–28 days depending on product. Do NOT freeze reconstituted solution. Protect from light. Very sensitive to agitation — do not shake.
Demonstrated Effects
- FDA-approved: Adult growth hormone deficiency (GHD), pediatric growth failure, Turner syndrome, Prader-Willi syndrome, HIV-associated wasting, short bowel syndrome
- Increases lean muscle mass and reduces visceral adipose tissue
- Improves bone mineral density and fracture risk
- Enhances athletic recovery and exercise capacity
- Improves skin thickness and reduces wrinkles (collagen stimulation)
- Elevates IGF-1 for systemic anabolic and tissue repair effects
- Improves lipid profile (reduces LDL, increases HDL)
- Enhanced energy, sleep quality, and cognitive function
- Supports wound healing and post-surgical recovery
- Cardiovascular protective effects in GH-deficient patients
Proposed Mechanisms of Action
1. IGF-1 Stimulation (Hepatic)
HGH binds GH receptors on hepatocytes, stimulating IGF-1 production. IGF-1 then mediates most of HGH's anabolic effects on muscle, bone, and cartilage via IGF-1R signaling.
2. Direct Lipolysis
HGH directly activates hormone-sensitive lipase in adipocytes, promoting triglyceride breakdown and fatty acid release for energy. Preferentially affects visceral adipose tissue.
3. Protein Synthesis Enhancement
Both direct GH signaling and IGF-1-mediated pathways (PI3K/Akt/mTOR) enhance muscle protein synthesis and nitrogen retention, supporting lean mass accretion.
4. GH Receptor / JAK2-STAT5 Signaling
HGH binds the GH receptor, activating JAK2 kinase which phosphorylates STAT5. STAT5 translocates to the nucleus to drive IGF-1 gene expression and other anabolic gene programs.
5. Insulin Antagonism
At higher doses, HGH exerts anti-insulin effects, raising blood glucose by reducing peripheral glucose uptake — relevant for diabetes risk at supraphysiological doses.
6. Collagen and Bone Matrix Synthesis
HGH and IGF-1 stimulate osteoblast activity, collagen type I synthesis, and chondrocyte proliferation, improving bone mineral density and connective tissue quality.
Research Evidence & Clinical Data
Investigated Applications
Body Composition (Muscle Gain / Fat Loss)
Anecdotal: HighHGH is one of the most potent agents for improving body composition — simultaneously reducing body fat (particularly visceral) and preserving or increasing lean muscle mass. Effects are gradual but substantial over 3–6 month cycles.
Preclinical basis: HGH activates hormone-sensitive lipase in adipocytes promoting lipolysis, while stimulating IGF-1-mediated muscle protein synthesis. Direct lipolytic and anti-lipolytic regulation of adipose tissue is well-characterized.
Anti-Aging and Longevity
Anecdotal: ModerateThe progressive decline of GH/IGF-1 axis with aging (somatopause) has led to interest in GH replacement for anti-aging. Benefits include improved body composition, skin quality, bone density, and energy. Long-term safety remains debated given IGF-1's role in cellular proliferation.
Preclinical basis: Rudman D et al. (NEJM 1990): Landmark study demonstrating HGH replacement in elderly men produced lean mass increase, fat loss, and skin thickness improvement equivalent to 10–20 years of age reversal.
Recovery and Injury Healing
Anecdotal: HighHGH strongly promotes tissue repair, collagen synthesis, and recovery from injuries and surgeries. It is used by athletes for accelerated return to training after injuries and by post-surgical patients (sometimes under medical supervision).
Preclinical basis: HGH elevates IGF-1 which directly promotes satellite cell activation, collagen synthesis, and angiogenesis in healing tissue. Well-documented in sports medicine literature.
Safety Profile
Common Side Effects
- Water retention and edema (especially fingers, ankles)
- Carpal tunnel syndrome (nerve compression from fluid retention)
- Joint pain (arthralgias)
- Insulin resistance / elevated fasting glucose at higher doses
- Headaches
- Injection site reactions
Contraindications
- Active malignancy — HGH promotes cellular proliferation (absolute contraindication)
- Proliferative diabetic retinopathy or severe non-proliferative retinopathy
- Closed epiphyses in pediatric patients with non-GHD indications
- Prader-Willi syndrome with severe obesity/respiratory impairment
- Critical illness (acute intensive care) except specific approved uses
Legal & Regulatory Status
FDA-approved pharmaceutical (somatropin) for specific indications: adult GHD, pediatric growth failure, Turner syndrome, Prader-Willi syndrome, HIV wasting, short bowel syndrome. Off-label use for anti-aging and performance is not FDA-approved. Schedule III controlled substance in the US under the Anabolic Steroid Control Act (1990 amendment). WADA prohibited at all times. Prescription-only in US, EU, and most regulated markets. Available via compounding pharmacies in some jurisdictions.
Fármaco farmacéutico aprobado por FDA (somatropina) para indicaciones específicas: deficiencia de GH en adultos, insuficiencia de crecimiento pediátrico, síndrome de Turner, síndrome de Prader-Willi, caquexia por VIH, síndrome de intestino corto. Uso fuera de indicación para antienvejecimiento y rendimiento no está aprobado por FDA. Sustancia controlada Schedule III en EE.UU. bajo la Ley de Control de Esteroides Anabólicos (enmienda 1990). Prohibida por WADA en todo momento. Solo con receta en EE.UU., UE y la mayoría de mercados regulados. Disponible vía farmacias de compoundación en algunas jurisdicciones.
Research Protocols
Dosing Protocols
Routes of Administration
subcutaneous
Reconstitution Guide
Pharmacokinetics
| Half-Life | Sub-Q injection: half-life ~2.5–3.8 hours. Plasma IGF-1 elevation persists 24+ hours after GH pulse. |
Monitoring & Risk Management
Ongoing Monitoring Steps
- IGF-1 level every 4–6 weeks — maintain within physiological range (150–300 ng/mL)
- Fasting glucose and HbA1c every 3 months
- Thyroid panel (TSH, free T4) every 6 months
- Blood pressure monitoring monthly
- Joint pain and water retention assessment at each check-in
- Annual cancer screening per age-appropriate guidelines
Critical Warning Signs
- New or worsening edema — dose reduction required
- Carpal tunnel symptoms (numbness, tingling in hands) — reduce dose
- Elevated fasting glucose or HbA1c — reassess dose; consider stopping
- Severe joint pain — discontinue and evaluate
- Any new lump, mass, or rapidly growing tissue — stop immediately
- Vision changes — ophthalmology evaluation urgently
Featured in Stacking Protocols
Community-researched combinations involving this compound